🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate that treatment with a 6-monthly...
Status
Terminated
Location
The Crouch Oak Family Practice
Start Date
2012-08
Trial ID
NCT01673984
Treatments Being Tested
The goal of this clinical research study is to find out how treatment with ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01088529
Treatments Being Tested
This is an observational study in which patient data from the past on men w...
Status
Completed
Location
Databases
Start Date
2022-01-17
Trial ID
NCT05149131
Treatments Being Tested
Among ER+HER2- premenopausal patients with N1 who undergoes primary breast ...
Status
Recruiting
Location
Gangnam Severance Hospital
Start Date
2023-02-06
Trial ID
NCT05333328
Treatments Being Tested
Erlotinib attacks a part of cancer cells that helps them live and grow. Stu...
Status
Terminated
Location
Vanderbilt-Ingram Oncology Cool Springs
Start Date
2010-05
Trial ID
NCT01205685
The present study is a randomized open-label -phase III study that aims to ...
Status
Unknown
Location
FUSCC
Start Date
2008-05
Trial ID
NCT01352091
Treatments Being Tested
The purpose of this study is to compare 5-year disease free survival rate (...
Status
Unknown
Location
Department of Surgery, Korea Cancer Center Hospital
Start Date
2009-05
Trial ID
NCT00912548
The primary objective is to evaluate whether Zoladex 10.8 mg (12-weekly) is...
Status
Completed
Location
Research Site
Start Date
2006-04
Trial ID
NCT00322348
Treatments Being Tested
The proposed clinical trial will study the effects of 12 months of therapy ...
Status
Completed
Location
Multiple Locations
Start Date
2013-03-04
Trial ID
NCT01790126
Treatments Being Tested
This open-label study is designed to obtain preliminary data on the efficac...
Status
Completed
Location
Exdeo Clinical Research Inc.
Start Date
2017-02-21
Trial ID
NCT04060043
Treatments Being Tested